Neonatal Sepsis and the Use of Extracorporeal Therapy Methods: A Clinical Case
Основное содержимое статьи
Аннотация
Abstract
Neonatal sepsis remains one of the leading causes of mortality among newborns, with Klebsiella pneumoniae being one of the most common etiological agents. This article presents the first successful case in Kazakhstan of hemofiltration use in a neonate with sepsis caused by Klebsiella pneumoniae ESBL 10⁷ CFU/ml. The case highlights the clinical characteristics, decision-making process, and effectiveness of prolonged veno-venous hemofiltration (PVVHF) as adjunctive therapy. Hemofiltration contributed to hemodynamic stabilization, correction of metabolic acidosis, reduction of inflammatory markers, and successful extubation, demonstrating the potential role of extracorporeal therapies in critically ill neonates.
Информация о статье
##plugins.generic.dates.accepted## 2025-12-18
##plugins.generic.dates.published## 2025-12-18
Библиографические ссылки
Saetang P., Samransamruajkit R., Singjam K., Deekajorndech T. Polymyxin B Hemoperfusion in Pediatric Septic Shock: Single-Center Observational Case Series // Pediatric Critical Care Medicine. – 2022. – Vol. 23(8). – P. e386–e391. https://doi.org/10.1097/PCC.0000000000002969.
Bottari G., Guzzo I., Marano M., Stoppa F., Ravà L., Di Nardo M., Cecchetti C. Hemoperfusion with Cytosorb in Pediatric Patients with Septic Shock: A Retrospective Observational Study // International Journal of Artificial Organs. – 2020. – Vol. 43(9). – P. 587–593. https://doi.org/10.1177/0391398820902469.
Siripanadorn T., Samransamruajkit R. The Role of Blood Purification by HA330 as Adjunctive Treatment in Children with Septic Shock // Blood Purification. – 2023. – Vol. 52(6). – P. 549–555. https://doi.org/10.1159/000530446.
Bottari G., Lorenzetti G., Severini F., Cappoli A., Cecchetti C., Guzzo I. Role of Hemoperfusion with CytoSorb Associated with Continuous Kidney Replacement Therapy on Renal Outcome in Critically Ill Children with Septic Shock // Frontiers in Pediatrics. – 2021. – Vol. 9. – P. 718049. https://doi.org/10.3389/fped.2021.718049.
Bottari G., Severini F., Markowich A. H., Lorenzetti G., Ruiz Rodriguez J. C., Ferrer R., Francalanci P., Ammirati A., Palma P., Cecchetti C. Hemoadsorption for Severe MIS-C in Critically Ill Children: Should We Consider It as a Therapeutic Opportunity? // International Journal of Artificial Organs. – 2022. – Vol. 45(10). – P. 871–877. https://doi.org/10.1177/03913988221111179.
Taccone F.S., Brunkhorst F.M., Bottari G., Hidalgo J., Kribben A., Teboul J.L., Tomescu D., Klaus T., Scheier J., Deliargyris E., Ferrer R. The COSMOS Registry of CytoSorb Hemoadsorption Therapy in Critically Ill Patients: Protocol for an International, Prospective Registry // JMIR Research Protocols. – 2024. – Vol. 13. – P. e55880. https://doi.org/10.2196/55880.
Cavagnaro Santa María F., Roque Espinosa J., Guerra Hernández P. Continuous Venovenous Hemofiltration in Neonates with Hyperammonemia: A Case Series // Revista Chilena de Pediatría. – 2018. – Vol. 89(1). – P. 74–78. https://doi.org/10.4067/S0370-41062018000100074.
Noh E.S., Kim H.H., Kim H.S., Han Y.S., Yang M., Ahn S.Y., Sung S.I., Chang Y.S., Park W.S. Continuous Renal Replacement Therapy in Preterm Infants // Yonsei Medical Journal. – 2019. – Vol. 60(10). – P. 984–999. https://doi.org/10.3349/ymj.2019.60.10.984.
Cortina G., Daverio M., Demirkol D., Chanchlani R., Deep A. Continuous Renal Replacement Therapy in Neonates and Children: What Does the Paediatrician Need to Know? // European Journal of Pediatrics. – 2024. – Vol. 183(2). – P. 351–364. https://doi.org/10.1007/s00431-023-05318-0.
Killick C.J., Smith E., MacLaren G. Provision of Continuous Renal Replacement Therapy in Children: A 5-Year Review of Practice and Outcomes in the UK // Pediatric Nephrology. – 2024. – Vol. 39(5). – P. 1023–1032. https://doi.org/10.1016/j.pedneo.2024.04.006.
Feng S., Cui Y., Zhou Y., Shao L., Miao H., Dou J., Liu T., Wang C., Zhang Y. Continuous Renal Replacement Therapy Attenuates Expansion of Myeloid-Derived Suppressor Cells in Paediatric Sepsis // Frontiers in Immunology. – 2022. – Vol. 13. – P. 990522. https://doi.org/10.3389/fimmu.2022.990522.
Bottari G., Guzzo I., Marano M., Stoppa F., Ravà L., Di Nardo M. Hemadsorption with CytoSorb® in Infants and Children with Sepsis: A Nonsystematic Review of Paediatric Cases // Journal of Clinical Medicine. – 2024. – Vol. 13(22). – P. 6808. https://doi.org/10.3390/jcm13226808.
Köker A., Yaman A., Akkuzu E., Duyu M., Akçay N., Dalkıran T., Besci T., Demet Demirkol. Continuous Renal Replacement Therapy (CRRT) Protocol in Critically Ill Children: A Single-Center Experience and Literature Review // Pediatric Nephrology. – 2024. – Vol. 39(2). – P. 347–356. https://doi.org/10.1007/s00467-023-05600-x.
Saeed A., Jafarian H., Amanati A. Effective Management of Paediatric Septic Shock: A Case Study Utilising Continuous Renal Replacement Therapy with CytoSorb® and Citrate in a Leukemic Child with Hyper-IL-6-Emia and Severe Thrombocytopenia // BMC Infectious Diseases. – 2025. – Vol. 25. – P. 410. https://doi.org/10.1186/s12879-025-10807-8.